Skip to main content

Table 2 Incremental cost-effectiveness

From: Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa

  Costs Effectiveness Cost-effectiveness
  Incremental costs HbA1c reduced QALYs gained ICER (HbA1c) ICER (QALYs)
Intervention $594.27 0.53 0.05 $1121.26 $13 191.24
  1. Note: Incremental costs shown in Table 3